#66. Quantitative Systems Pharmacology

<p>In this episode, we explore the evolving role of <strong>Quantitative Systems Pharmacology (QSP)</strong> in drug development, particularly as a mechanistic alternative to traditional animal testing. It details how mathematical modeling can integrate <strong>human-relevant data</strong> and <strong>biological pathways</strong> to better predict drug safety and efficacy before clinical trials. The sources highlight recent <strong>2026 FDA draft guidances</strong> that establish a regulatory framework for using these models to select initial human doses. While the text acknowledges that QSP is not yet a total replacement for animal studies, it proposes a <strong>staged roadmap</strong> for its integration. This strategy emphasizes combining computational models with <strong>New Approach Methodologies (NAMs)</strong>, such as organoids, to improve translatability. Ultimately, the documentation serves as a guide for achieving <strong>regulatory-grade validation</strong> and shifting toward more ethical, human-centric pharmacology. Produced by Dr. Jake Chen.</p>